Glass Particles Trigger a Nationwide Recall of an Arthritis Infusion Drug Given in Clinics and Hospitals

Fresenius Kabi recalled one lot of Tyzenne, a tocilizumab infusion drug, after finding glass particles. The response falls on providers.

Have A Referral?